Pharma Industry News

Epidarex Capital closes life sciences venture fund at £102m

New UK fund underpinned by £50 million investment from the British Business Bank, via its Enterprise Capital Funds (ECF) programmeOriginal Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]